Clinical Trial Update: A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating darbepoetin alfa for treating anemia in patients with non-myeloid malignancies receiving multi-cycle chemotherapy has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Non-myeloid Malignancies

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)

Snippet

Sponsor: Amgen | Conditions: Anemia, Non-Myeloid Malignancies | Phase 3 | Status: COMPLETED